Despite lack of a somatic second hit in MSH2, BC22 was interpreted as having Lynch syndrome rather than CMMRD due to lack of clinical signs of CMMRD and the preserved expression of MSH2 and MSH6 in normal cells based on immunohistochemistry. The gene discussed is MSH2; the disease is Lynch syndrome.